baseline clinical characteristics (facility, age, gender, body mass index, use of antihypertensives, eGFR and urine protein), therapeutic interventions within 1 year of diagnosis (use of RAAS blockers and corticosteroid/immunosuppressants) ,genotypes of ICAM-1 A1548G (1548AA, AG and GG).